The Diplomat
Técnicas Reunidas has signed an agreement with Abu Dhabi National Oil Company (ADNOC) to bid for several contracts totaling $1 billion (850 million euros) over the next five years.
According to the company, ADNOC has selected the Spanish company to sign a framework agreement that will allow the Spanish company to compete with other leading international firms for contracts in Abu Dhabi (United Arab Emirates). The objective of these contracts is the development of conceptual engineering and advanced engineering services (FEED) necessary for the execution of various projects that the Arab company, one of the largest in the world in its sector, considers essential to achieve the fulfillment of its Strategy 2030.
Técnicas Reunidas will participate in these projects through joint-venture collaboration with its local partner, the National Petroleum Construction Company (NPCC), and competing with seven other leading international engineering companies: AMEC International (Wood Group), Fluor, McDermott, Mott MacDonald, SNC-Lavalin International Arabia Limited (Kentech Group), Technip Energies and Worley.
“The signing of this framework agreement is a positive recognition of our company’s competitive level and its ability to establish reliable and lasting relationships with the main clients in the region,” said Arturo Crossley, Chief Commercial Officer of Técnicas Reunidas. The term of the framework agreement signed by the Spanish company will run from 2021-2026, with an option to extend for a further two years.
Técnicas Reunidas is one of the most important companies in its sector on an international scale, with a presence in 25 countries and a track record that totals more than 1,000 industrial plants in its 60 years of experience. Its activity is mainly focused on engineering projects, the development of industrial plants for the production of clean fuels and petrochemical products, the production and processing of natural gas, and the promotion of advanced low carbon emission technologies, such as green hydrogen, CO2 sequestration and capture, biofuels, waste recovery, etc. It has more than 7,500 employees, most of them highly qualified engineers, and its revenues reached 3.5 billion euros in 2020.
Galician pharmaceutical company Pharmamar enters the United Arab Emirates
On the other hand, the Galician biopharmaceutical company Pharmamar announced last Tuesday the approval to market Zepzelca (lurbinectedin) in the United Arab Emirates. Thanks to this approval, the company’s flagship drug against microcritical lung cancer will be able to conquer a new market, following trials with 105 adults.
“This is the second authorization of lurbinectedin by a regulatory agency, which will provide recurrent small-cell lung cancer patients with a new treatment option in the United Arab Emirates,” said Luis Mora, CEO of Pharmamar’s Oncology and Virology Business Units.
